Literature DB >> 2891536

Effect of 6-hourly intermittent intravenous boluses of oxmetidine and ranitidine on gastric acidity and serum prolactin.

U R Fölsch1, G C Wichmann, A Torossian.   

Abstract

The effect on 24-h gastric juice volume and pH of 30 min intravenous infusions of 200 and 400 mg oxmetidine and 50 mg ranitidine, administered at 6-hourly intervals, has been investigated in 12 healthy male subjects. After each infusion period a median intragastric pH greater than 5 was obtained with all active treatments, which also caused a significantly elevated 24-h median pH versus placebo. The 24-h median pH following ranitidine did not differ significantly from that after either oxmetidine treatment. There was a sharp decrease in gastric volume secretion within 2 h of infusion of each active treatment. There was no significant difference between active treatments in the time required to reach an intragastric pH greater than 5. No active treatment was able to maintain the pH greater than 5 for longer than 4 h (average 3 h). It is concluded that in patients at risk of stress ulcer, continuous infusion therapy with H2-blockers should be employed both for pharmacokinetic and practical reasons. It should be accompanied by regular measurement of pH in order to monitor any fall in pH. Alternatively, shorter time intervals than 6 h should be used for bolus therapy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2891536     DOI: 10.1007/bf00637560

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  Antacid titration in the prevention of acute gastrointestinal bleeding: a controlled, randomized trial in 100 critically ill patients.

Authors:  P R Hastings; J J Skillman; L S Bushnell; W Silen
Journal:  N Engl J Med       Date:  1978-05-11       Impact factor: 91.245

2.  Positioning of subject and of nasogastric tube during a gastric secretion study.

Authors:  M A Hassan; M Hobsley
Journal:  Br Med J       Date:  1970-02-21

3.  Effect of three single doses of oxmetidine administered intravenously on the volume and acidity of gastric secretion, serum prolactin and gastrin concentration in healthy volunteers.

Authors:  G C Wichmann; U R Fölsch; E von Kleist; F M Hasse; M Dillon; B Clowdus; W Creutzfeldt
Journal:  Z Gastroenterol       Date:  1984-06       Impact factor: 2.000

4.  [Intragastric acidity, serum gastrin and serum levels of the H2 receptor oxmetidine administered by continuous infusion].

Authors:  G C Wichmann; R Körber; U R Fölsch
Journal:  Arzneimittelforschung       Date:  1985

5.  Control of gastric pH with cimetidine: boluses versus primed infusions.

Authors:  M J Ostro; J A Russell; S J Soldin; W A Mahon; K N Jeejeebhoy
Journal:  Gastroenterology       Date:  1985-09       Impact factor: 22.682

6.  The prevention of upper gastrointestinal tract bleeding in patients in an intensive care unit.

Authors:  M J Zinner; G D Zuidema; M Mignosa
Journal:  Surg Gynecol Obstet       Date:  1981-08

7.  Oxmetidine: clinical pharmacological studies with a new H2-receptor antagonist.

Authors:  J G Mills; P L Brunet; R Griffiths; R H Hunt; D Vincent; G J Milton-Thompson; W L Burland
Journal:  Gut       Date:  1982-02       Impact factor: 23.059

8.  Antacid versus cimetidine in preventing acute gastrointestinal bleeding. A randomized trial in 75 critically ill patients.

Authors:  H J Priebe; J J Skillman; L S Bushnell; P C Long; W Silen
Journal:  N Engl J Med       Date:  1980-02-21       Impact factor: 91.245

9.  [Ranitidine and cimetidine in the prevention of stress: ulcer hemorrhage a prospective comparative multicenter study].

Authors:  H O Barth; P Berg; G Brunner; H G Dammann; W Friedl; F H Franken; L Greiner; J Groitl; W Möckel; P Müller
Journal:  Langenbecks Arch Chir       Date:  1984

10.  Predictive value of intramural pH and other risk factors for massive bleeding from stress ulceration.

Authors:  R G Fiddian-Green; E McGough; G Pittenger; E Rothman
Journal:  Gastroenterology       Date:  1983-09       Impact factor: 22.682

View more
  1 in total

Review 1.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.